Milestone Pharmaceuticals Inc. Annual Return On Equity in % from 2019 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Milestone Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
  • Milestone Pharmaceuticals Inc. Return On Equity for the quarter ending June 30, 2024 was -165 %, a 67.3% decline year-over-year.
  • Milestone Pharmaceuticals Inc. annual Return On Equity for 2023 was -171 %, a 142% decline from 2022.
  • Milestone Pharmaceuticals Inc. annual Return On Equity for 2022 was -70.6 %, a 111% decline from 2021.
  • Milestone Pharmaceuticals Inc. annual Return On Equity for 2021 was -33.5 %, a 27.4% increase from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -171 -100 -142% Jan 1, 2023 Dec 31, 2023
2022 -70.6 -37.1 -111% Jan 1, 2022 Dec 31, 2022
2021 -33.5 +12.7 +27.4% Jan 1, 2021 Dec 31, 2021
2020 -46.2 +1.2 +2.53% Jan 1, 2020 Dec 31, 2020
2019 -47.4 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.